Scope: The Scope of the conference is to gather all the Physicians, Researchers, Business Delegates and Scientists to approach and deliver all the attendees about the latest scientific advancements on the particular sphere of influence. This Epigenetics and Epitranscriptomics Conference is the premier event focusing on understanding in individual and organizational behaviour and decision-making related to genetics and molecular biology, biotechnology, pharmaceuticals, medicals, and academia.

Importance:  Conference on Epitranscriptomics 2019 is a much-celebrated conference which basically deals with the latest research and developments in the sphere of genetics and molecular biology .This Conference will give a culminate stage to all the worldwide blend of driving Investigate researchers, and researchers accomplished significance in their field of think about, investigate academicians from the colleges and investigate teach, mechanical inquire about experts and trade partners along with Ph.D.

TARGET AUDIENCE:

The conference discusses the latest research outcomes and technological advancements in the field of genetics and molecular biology.

•           Scientists

•           Epigenetics, Genetics and Oncology Researchers

•           Human Genetics/ Epigenetics/Cancer Associations and Society

•           Molecular Biologists

•           Business delegates

•           Directors, Board Members, Presidents, Vice Presidents

•           Cell Biologists

•           CEO's and R&D Heads from Industries

•           Business Entrepreneurs and Industrialists

•           Human Genetics Researchers

•           Pharmacists

•           Drug Manufacturing Companies and Industries

•           Laboratory Technicians and Diagnostic Companies

TARGET AUDIENCE:

                Industry               60%

                Academia            35%

                Others                  05%

Today’s Market Study of Epitranscriptomics research in USA | Europe | Middle East | Asia Pacific

Asia pacific: The Europe genetic testing market is valued at USD 1.20 billion in 2016, and is projected to reach USD 1.6 billion by 2021, growing with a compound annual growth rate (CAGR) of 8.2% during the forecast period, 2016-2020.

USA:  The USA Genetics market is poised to reach USD 19.99 Billion by 2020, growing at a CAGR of 9.9% during the forecast period of 2015 to 2020.

Europe: The global Epigenetic value on market was estimated $419.4 million in 2013 and is expected to grow at a CAGR of 13.9% in the next five years.

Middle East: The global gene expression analysis market is projected to reach USD 5.30 Billion by 2020 from USD 3.39 Billion in 2015, at a CAGR of 9.3% from 2015 to 2020. The primary growth appliance in this region is China, which is expected to record a growth rate of 12.5% in the forecast period.

The falling sequencing expenses and time increase in research activities to identify and progress inhibitors/drugs for various diseases, funding for epigenetics research, and rising the prevention of cancer are the major factors driving the progression of this market.

The global market for Epigenetic Testing is forecast to reach US$2.4 billion by 2018. Increasing knowledge about the potential benefits in Epigenetic testing is one of the prime reasons for the growth of the genetic analysis. Developments in the genetic modifications space, aging population and a consequent rise in the number of genetic diseases, and increasing incidence of cancer cases are the other factors impelling growth in the genetic testing market.

Global Epigenetics Market, by Research Areas

• Developmental Biology
• Drug Discovery
• Oncology
• Other Epigenetics Research Areas

Genetic and Epigenetic risk Factors:

Epidemiological and clinical studies have shown that children exposed to adverse experiences are at increased risk for the development of depression, anxiety disorders, and posttraumatic stress disorder (PTSD). A history of child abuse and maltreatment increases the likelihood of being subsequently exposed to traumatic events or of developing PTSD as an adult. The brain is highly plastic during early life and encodes acquired information into lasting memories that normally subserve adaptation. Epigenetic phenomena are increasingly recognized as important drivers of disease risk, like diabetic Kidney Disease and various cancers.

Glance at the Market

Some key players of the epigenetics market incorporate, Abcam, Illumina, Diagenode, Thermo Fisher Scientific, Merck, Zymo research, Qiagen, CellCentric Ltd, Chroma Therapeutics Ltd, Eisai Co. Ltd, Novartis International AG., Syndax Pharmaceuticals, Inc., Valirx Plc and Sigma-Aldrich Corporation, Oncolys Biopharma Inc.

Extensive R&D activities went for the advancement of novel medications and the nearness of solid item pipeline is relied upon to further help market development over the gauge time frame.Grand View Research has fragmented the global epigenetics market on the basis of product, technology, application and region:

Epigenetics Product Outlook (Revenue, USD Million, 2015 – 2022)

·        Reagents

·         Kits

·         Instruments

·         Enzymes

·         Services

Epigenetics Technology Outlook (Revenue, USD Million, 2015 – 2022)

·         DNA Methylation

·         Histone Methylation

·         Histone Acetylation

·         Large noncoding RNA

·         MicroRNA Modification

·         Chromatin structures

Epigenetics Application Outlook (Revenue, USD Million, 2015 – 2022)

·         Oncology

·         Solid Tumors

·         Liquid Tumors

·         Non Oncology

·         Inflammatory Diseases

·         Metabolic Diseases

·         Infectious Diseases

·         Cardiovascular Diseases

Epigenetics Market Regional Outlook (Revenue, USD Million, 2015 – 2022)

·         North America

·         U.S.

·         Canada

·         Europe

·         UK

·         Germany

·         Asia Pacific

·         Japan

·         China

·         India

·         Latin America

·         Brazil

·         Mexico

·         Middle East and Africa (MEA)

·         South Africa

Why it’s in Helsinki?

Helsinki is the capital of Finland, vibrant seaside of attractive islands and prodigious green parks. Helsinki’s is been awarded with City of Design status by UNESCO. The population of 1.4 million makes it the most populous metropolis and urban area in Finland with important political, educational, financial, cultural and research centre. The capital of Finland is filled with lively events all year round. Design Scene, Architectural Innovations, Finnish Flavours, Natural Environment add colours to Helsinki.

Scientists in Finland are working on making stem cells as key to youth. Stem cell research is widely recognised and funded in European Countries where researchers doing great work on stem cell and regenerative medicine.  In fact, ensuing the principle that stem cell research provides vast prospective to create new treatments for several serious diseases such as diabetes and heart disease. The location of the Helsinki Airport is the neighbouring city of Vantaa, which has frequent service to

many destinations in Europe and Asia. Helsinki was the World Design Capital for 2012.

 LIST OF UNIVERSITIES AROUND THE GLOBE:

University of Oxford

University of Washington

Stanford University

University of Tokyo

University of Cambridge

Icahn School of Medicine at Mount Sinai

University of Queensland Australia

McGill University

University of British Columbia

Aix-Marseille Universities

Karolinska Institute

University of Helsinki

London School of Hygiene & Tropical Medicine

University of Chicago

Top universities in Finland:

University of Helsinki

University of Tampere

Abo Akademi University

University of Oulu

University of Eastern Finland

University of Jyväskylä

Tampere University of Technology

University of Turku

Aalto University

Lappeenranta University of Technology

Track 1. Epigenetics

The study of heritable changes in gene expression that occur without a change in DNA sequence (i.e., an adjustment in phenotype without an adjustment in genotype) is called Epigenetics. In all living organisms, epigenetic controls are essential for normal development and they become misdirected in cancer cells and other human disease syndromes. Epigenetic modifications can marked such as the manner in which cells terminally differentiate to transpire as skin cells, liver cells, brain cells, etc. The epigenetic alterations having more damaging effects that can result in diseases like cancers.

There are two primary and interrelated epigenetic mechanisms: DNA methylation and covalent modification of histones.

Track 2. Epigenetic Mechanisms

The epigenetic component is to allude complex intelligent between the mapping of genome and the environment that are included in advancement and separation in higher living beings. The heritable changes that are not due to changes in DNA sequence, but it will happened DNA methylation and histone adjustment. The changes of DNA availability and chromatin structure, subsequently directing designs of quality expression. These forms are basic to ordinary improvement and separation of person cell ancestries in the grown-up life form. They can be reformed by exogenous effects; as such can contribute to the result of natural alterations of phenotype or pathophenotype.

Track 3. Genomes and Epigenomes                         

Epigenomes are made up of some chemical compounds and proteins which will attribute some genes and DNA that monitoring the production of proteins in a particular cell. The epigenomes have many alterations to the genome and some specialized cell that makes protein.

The chemical modifications of epigenomes to the DNA and DNA-associated proteins in the cell, which alter gene expression, and are heritable. The variations occur as a tissue development and differentiation that can be altered in response to environmental exposures and diseases. The epigenome has immediate applications for diagnostics. Changes to the epigenome can result in changes to the structure of chromatin and changes to the function of the genome.

Track 4. Computational Epigenetics

The current field of epigenetics includes a few mechanisms, including DNA methylation, histone modification, and microRNAs.DNA methylation is a covalent modification, heritable by somatic cells after cell division. Epigenetic modifications influence phenotype through heritable regulation of gene expression. The environment-induced epigenetic defects are known to play a major role in cancer and ageing.

Track 5. Epigenetics and Environmental Origins of Cancer

The Identification of epigenetic occasions discharged by particular natural and presence stressors, and these discoveries proceed to amplify our understanding of the mechanism of carcinogenesis, particularly those linked to risk-factor exposures and aging. In addition, important insights into epigenetic mechanisms and associated exposure risk factors have had a functional impact of specific human cancers. Environmental contaminants are linked to impacts on human health and consequences of combustion to contaminating trace metals and residual organic compounds used in daily life.

Track 6. Epigenetics in Cardiovascular Disease

The DNA methylation, post translational histone modifications, and microRNA regulation are key mechanisms underlying healthy cardiovascular function as well as heart disease and its precursors. There is increasing evidence for the involvement of epigenetics in human disease such as cancer, inflammatory disease and CV disease. Other chronic diseases are also susceptible to epigenetic modification such as metabolic diseases including obesity, metabolic syndrome, and diabetes mellitus. There is much evidence for the modification of epigenetics by nutrition and exercise. Epigenetics are also involved in cardiovascular risk factors such as smoking, diabetes and hypertension. Gene expression regulation through the interplay of DNA methylation and histone modifications is well-established, although the knowledge about the function of epigenetic signatures in cardiovascular disease is still largely unexplored

Track 7. Pharmacogenomics & Personalized Medicine

The practices of personalized medicine are to maximize the therapeutic efficiency of likelihood and to minimize the risk of drug toxicity for an individual patient. Pharmacogenomics is the study of the genome in drug response. The genetic disorder occurrence is quite rare in population; some might be hereditary while the others are caused by mutations. Disease-specific epigenetic signatures such as DNA methylation, hydroxymethylation, and non-coding RNAs are now being utilized clinically for prognostics and diagnostics, while an expanding collection of genetically aberrant, abnormally expressed or chromatin-interacting epigenetic enzymes are positioned as promising targets for therapeutic intervention.

Track 8. Nutritional Epigenetics

Nutritional epigenetics is to clarify the effects of nutrition on gene expression. It serves as a site to specify and illustrate new concepts of metabolism and food emergent. Nutritional epigenetics has been observed as an attractive implement to prevent pediatric developmental diseases and cancer as well as to delay aging-associated processes. In recent years, epigenetics has become an emerging issue in a broad range of diseases such as type 2 diabetes mellitus, obesity, inflammation, and neurocognitive disorders.

Nutritional genomics pursues to expand the use of foods to reach human genetic potential, while reducing the risk of diseases.

Track 9. Epigenetic Diseases – Clinical Applications

It is the application of molecular biology techniques to detecting alterations in DNA methylation or histone modification to analyze the study of disorders characterized by heritable defects in the expression of a gene or genome. While epigenetic changes are required for normal development and health, they can also be responsible for some disease states. Disturbing any of the three frameworks that contribute to epigenetic modifications can cause unusual actuation or quieting of qualities. Such disturbances have been related with cancer, disorders including chromosomal dangers, mental hindrance and immune responses. Numerous maladies counting cancer, heart infection, diabetes and mental sicknesses are impacted by epigenetic instruments.

Track 10. Current Case studies in Epigenetics and Epitranscriptomics

It is the knowledge of epigenetics, combined with rise of technologies such as CRISPR/Cas9 gene editing and next-generation sequencing. In recent years, it permits us to superior recognize the interaction between epigenetic alter, quality direction, and human diseases, and will lead to the improvement of unused approaches for atomic determination and focused on molecular medicines over the clinical range. Recent technical advances such as ChIP-on-ChIP and ChIP-seq have started to convert epigenetic research. The advance knowledge in the field is to understand the basic biology and human diseases, the catalyzing adoption of epigenetics or epitranscriptomics methods. Finally, the advancement of current approaches, coupled with new technologies, will allow for the development of new therapies and therapeutic targets for human diseases associated with deficient RNA modification.

Track 11. Plant Epigenetics

Epigenetic component makes a difference to ensure the plant cells from the action of parasitic groupings such as transposable components, this defense can complicate the hereditary designing prepare through transcriptional quality silencing. The frequently occurring changes in plants which incorporates heritable or metastable changes causing varieties in epigenetic status. Hence, heritable epigenetic varieties as well as hereditary variety have the potential to drive common varieties in plants. Climate alter is without a doubt one of the most prominent dangers confronting both plants and creatures alike. With rising temperatures and irregular climate designs, dry spells have gotten to be a distant as well typical event worldwide.

Track 12. Translational Epigenetics

The emerging promise of translational epigenetics is highlighted in a range of stimulating clinical experiments underway on epigenetic pathways which offer new therapeutic approaches to cancer. Epigenetic modifications such as DNA methylation, histone modifications and nucleosome remodeling have been found to be diagnostic hallmarks in a range of human tumors. The pathways which are regulated (or mis regulated) via histone modifications, DNA methylation and other epigenetic marks are being investigated as potential targets of such epi-drugs.

Track 13. Stem cells and Epigenetics 

The epigenetic basis of stem cell differentiation arises from the need to maintain gene expression patterns in both stem/progenitor cells and their differentiated progenies. As a stem cell differentiates, genes associated with self-renewal are down-regulated, while lineage-specific genes are activated. It then follows that the inherited epigenetic marks deposited on those genes must be reversible. Chromatin modifying enzymes with opposing activities play a key role in the dynamic regulation of epigenetic marks. Defining the signaling pathways of these enzymes induced by differentiation-inducing cues is critical to understanding the mechanisms underlying stem cell differentiation. Furthermore, non-coding RNAs, especially microRNAs, provide additional layers for regulation of gene expression during cell fate specification. These multiple layers of regulation allow for rapid transition of proliferating stem cells into their differentiated progenies.

Track 14. Epigenetic Drug Discovery

Immune-mediated infections are clinically heterogeneous but they share hereditary and pathogenic components. These infections may create from the transaction of hereditary variables and natural or way of life variables. A developing understanding of how epigenetic instruments control quality expression designs and cell work has been helped by the advancement of small-molecule inhibitors that target these forms. These chemical instruments have made a difference to uncover the significance of epigenetics in directing cell destiny choices amid resistant reactions and have too highlighted the potential for focusing on epigenetic components for the treatment of aggravation and immune-mediated illnesses. The epigenetic dysregulation in cancers as well as encounters to epigenetic drug discovery with emerging biology and novel classes of drug targets.

Track 15. Epitranscriptomics

Epitranscriptomics can be defined as a functionally relevant change to the transcriptome that do not involve a change in the ribonucleotide sequence. The epitranscriptome, therefore, is defined as the study of posttranscriptional changes with vigour in both protein-coding and non-coding RNAs reveals a new complexity in gene regulation. Thus leading to 'Epitranscriptomics', organized with bioinformatics approaches and RNA modifications .There are a few sorts of RNA alterations that affect quality expression. These adjustments happen to all sorts of cellular RNA counting, but not constrained to, ribosomal RNA (rRNA), Transfer ribonucleic acid RNA (tRNA), Messenger RNA (mRNA), and little atomic RNA (snRNA). The most collective and well-understood mRNA alteration at show is the N6-Methyladenosine (m6A), which has been inspected to happen an normal of three times in each mRNA methylation.

Track 16. RNA editing in Epitranscriptomics

The transcriptome is widely and dynamically regulated by a network of RNA modifying factors. RNA editing enzymes APOBEC (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like) and ADAR (adenosine deaminase, RNA-specific) irreversibly recode primary RNA sequences, whereas newly described methylases (writers) and de-methylases (erasers) dynamically alter RNA molecules in response to environmental conditions. RNA modifications can affect RNA splicing, nuclear-cytoplasmic transport, translation, and regulation of gene expression by RNA interference. In addition, tRNA base modifications,processing, and regulated cleavage have been shown to alter global patterns of mRNA translation in response to cellular stress pathways .The epitranscriptomics, involves  in the enzymatic pathways that regulate these activities in cancer stem cell initiation and progression.

Track 17. Epitranscriptomics for Biomedical Discovery

Epitranscriptomics is the complete description and explication of chemical modifications of nucleotides found inside all classes of RNA that do not involve a change in the ribonucleotide sequence. the concepts of nucleotide modification, summarize transcriptome‐wide RNA modification gene mapping techniques, highlight recent studies exploring the functions of RNA modifications and their association to diseases.

The Epigenetic research contains the application of bioinformatics methods and the RNA modifications to resolve the epigenetic problems, as well as biomedical data analysis and academic modeling in epigenetics. This involves the effects of histone and DNA CpG island methylation. .A few techniques available to determine the global occurrence of a particular RNA modification. Thus, there is a need for the development of more high‐throughput techniques to characterize the full spectra of RNA modifications. It is also important to pursue the comprehensive identification and characterization of the enzymes responsible for RNA modification since several of these enzymes have been shown to play important roles in development and diseases.

Track 18. Epigenetics Biomarkers

Epigenetic biomarkers defined as the modifications of the genome with preserved DNA sequence. DNA methylation measurement in cell, it may also be useful in improving early detection by measuring tumor DNA released into the blood. Molecular biomarkers are used routinely in a clinical setting to assess the medical state of patients and in several other medical contexts, including clinical trial endpoints, pharmaceutical development, and basic science research. The clinical validation of epigenetic biomarkers to allow the accurate prediction of the outcome of cancer patients and their potential chemosensitivity to current pharmacological treatments. A clinical example of a biomarker is plasma glucose.

Track 19. Clinical studies of Epigenetics and Epitranscriptomics

Epigenetic changes, including DNA methylation, histone modifications, RNA epigenetics and nucleosome altering, are important for gene transcription, but such modifications do not conversion the coding sequence of the gene.  So epigenetic changes have been trusted into the lead of new drug discoveries. DNA utilize in cancer patients and hereditary or epigenetic interchanges particular to tumor DNA have been cautious in patients known with diverse sorts of cancer. Later inquire about proposes that our count calories and way of life can alter the expression of our qualities. This happens by altering epigenetic marks on best of our DNA without really making any changes to the fundamental hereditary disorders. For illustration, blueberries were found to epigenetically diminish DNA harm and drinking green tea may turn a few qualities on or off in women.

Related Associations or Societies:

USA:

American Society of Human Genetics (ASHG), National Society of Genetic Counsellors (NSGC), American College of Medical Genetics (ACMG), American Board of Genetic Counselling (ABGC), American Board of Medical Genetics (ABMG), Nation Coalition for Health Education in Genetics (NCHPEG), International Society of Nurses in Genetics (ISONG), Council of Regional Networks (CORN) discontinued, Canadian College of Medical Geneticists, College Canadian de Généticiens Médicaux (CCMG), Canadian Collaborative Group for Cancer Genetics (CCGCG), European Genetics Foundation (EGF), Clinical Molecular Genetics Society (CMGS) United Kingdom. The American Public Health Association, National Society of Genetic Counselors, International Mammalian Genome Society, British Society of Genetic Medicine, International Federation of Human Genetics Societies, Genetics society of America

Europe:

European Society Of Human Genetics, American Society of Human Genetics  ,German Genetics Society, International Society of Genetic Genealogy, The American Society of Haematology, ASGCT  American Society of Gene & Cell Therapy, International Society of Genetic Genealogy, Austrian Society for Human Genetics, Belgian Society for Human Genetics, Czech Society of Medical Genetics, Danish Society of Medical Genetics

Asia-Pacific and Middle East: 

East Asian Union of Human Genetics Societies, Association of Chinese Geneticists in America, Hong Kong Society of Medical Genetics, Japan Society of Human Genetics, Genetics Society of Korea (GSK), Korean Society of Human Genetics, Genetics Society of Vietnam, Turkish Association of Medical Genetics, Japan Society of Gene Therapy, Human Genetics Society of Australasia (HGSA), Australian Society of Genetic Counsellors ,Genetic Society of Australia (GSA),American Human Geneticists of Indian Subcontinent Origin, Indian Society of Human Genetics, National Laboratory for the Genetics of Israeli Populations, Israeli Society of Medical Geneticists, Middle East Genetics Association

3^rd Molecular Diagnostics Conference April 19-20, 2018, Dubai, UAE;

3^rd Stem Cell Conference, July 19-20, 2018, Dubai, UAE;

4^th synthetic biology Conference June11-12, Rome, Italy;

2^nd Cell Metabolism Summit September 19-20, 2018, Philadelphia, USA;

6^th Integrative Biology Conference May 21-23, 2018, Barcelona, Spain; 

Advanced Diabetes Conference, April 27-28, 2018, Abu Dhabi, UAE;

Paediatrics Conference, Molecular Genetics Conferences | Molecular Biology Congress | Biotechnology Meetings

3^rd Stem Cell Conference, July 19-20, 2018, Dubai, UAE; 

Rare Diseases Congress  August 27-29, 2018, Dubai, UAE;

3^rdMolecular Diagnostics Conference April 19-20, 2018, Dubai, UAE;

11^th Regenerative Medicine Congress July 19-20, 2018, Dubai, UAE;

2^nd Cell therapy Summit November 09-10, 2018, Atlanta, USA;

20^th biotechnology Congress March 05-07, 2018, London, UK; 

Organ Transplantation congress August 24-25, 2018, Tokyo, Japan;

4^th synthetic biology Conference June11-12, Rome, Italy;

9^th Tissue Science Conference July 13-14, 2018, Sydney, Australia;  

Pediatrics Conference, Jan-29-Feb01, 2018, Dubai, UAE;

World Biotechnology Congress, June 25-27, 2018, Dubai, UAE; 

World Vaccines Congress, June28-30, 2018, Dubai, UAE; 

Advanced Diabetes Conference, April 27-28, 2018, Abu Dhabi, UAE;

Biotechnology Conference, March 05-07, 2018, Dubai, UAE

Scope: The Scope of the conference is to gather all the Physicians, Researchers, Business Delegates and Scientists to approach and deliver all the attendees about the latest scientific advancements on the particular sphere of influence. This Epigenetics and Epitranscriptomics Conference is the premier event focusing on understanding in individual and organizational behaviour and decision-making related to genetics and molecular biology, biotechnology, pharmaceuticals, medicals and academia.

Importance:  Conference on Epitranscriptomics is a much celebrated conference which basically deals with the latest research and developments in the sphere of genetics and molecular biology .This Conference will give a culminate stage to all the Worldwide blend of driving Investigate Researchers, and Researchers accomplished significance in their field of think about, investigate academicians from the colleges and investigate teach, mechanical inquire about experts and trade partners along with Ph.D. Understudies to come and illuminate all the participants around the most recent logical progressions on the individual circle.

TARGET AUDIENCE:

The conference discusses the latest research outcomes and technological advancements in the field of genetics and molecular biology.

•           Scientists

•           Epigenetics, Genetics and Oncology Researchers

•           Human Genetics/ Epigenetics/Cancer Associations and Society

•           Molecular Biologists

•           Business delegates

•           Directors, Board Members, Presidents, Vice Presidents

•           Cell Biologists

•           CEO's and R&D Heads from Industries

•           Business Entrepreneurs and Industrialists

•           Human Genetics Researchers

•           Pharmacists

•           Drug Manufacturing Companies and Industries

•           Laboratory Technicians and Diagnostic Companies

TARGET AUDIENCE:

                Industry               60%

                Academia            35%

                Others                  05%

Today’s Market Study of Epitranscriptomics research in USA | Europe | Middle East | Asia Pacific

Asia pacific: The Europe genetic testing market is valued at USD 1.20 billion in 2016, and is projected to reach USD 1.6 billion by 2021, growing with a compound annual growth rate (CAGR) of 8.2% during the forecast period, 2016-2020.

USA:  The USA Genetics market is poised to reach USD 19.99 Billion by 2020, growing at a CAGR of 9.9% during the forecast period of 2015 to 2020.

Europe: The global Epigenetic value on market was estimated $419.4 million in 2013 and is expected to grow at a CAGR of 13.9% in the next five years.

Middle East: The global gene expression analysis market is projected to reach USD 5.30 Billion by 2020 from USD 3.39 Billion in 2015, at a CAGR of 9.3% from 2015 to 2020. The primary growth appliance in this region is China, which is expected to record a growth rate of 12.5% in the forecast period.

The falling sequencing expenses and time increase in research activities to identify and progress inhibitors/drugs for various diseases, funding for epigenetics research, and rising the preventation of cancer are the major factors driving the progression of this market.

The global market for Epigenetic Testing is forecast to reach US$2.4 billion by 2018. Increasing knowledge about the potential benefits in Epigenetic testing is one of the prime reasons for the growth of the genetic analysis. Developments in the genetic modifications space, aging population and a consequent rise in the number of genetic diseases, and increasing incidence of cancer cases are the other factors impelling growth in the genetic testing market.

Global Epigenetics Market, by Research Areas

·         Developmental Biology

·         Drug Discovery

·         Oncology

·         Other Epigenetics Research Areas

Genetic and Epigenetic risk Factors:

Epidemiological and clinical studies have shown that children exposed to adverse experiences are at increased risk for the development of depression, anxiety disorders, and posttraumatic stress disorder (PTSD). A history of child abuse and maltreatment increases the likelihood of being subsequently exposed to traumatic events or of developing PTSD as an adult. The brain is highly plastic during early life and encodes acquired information into lasting memories that normally subserve adaptation. Epigenetic phenomena are increasingly recognized as important drivers of disease risk, like diabetic Kidney Disease and various cancers.

Why it’s in Helsinki,??

Helsinki is the capital of Finland, vibrant seaside of attractive islands and prodigious green parks. Helsinki’s is been awarded with City of Design status by UNESCO. The population of 1.4 million makes it the most populous metropolis and urban area in Finland with important political, educational, financial, cultural and research centre. The capital of Finland is filled with lively events all year round. Design Scene, Architectural Innovations, Finnish Flavours, Natural Environment add colours to Helsinki.

Scientists in Finland are working on making stem cells as key to youth. Stem cell research is widely recognised and funded in European Countries where researchers doing great work on stem cell and regenerative medicine.  In fact, ensuing the principle that stem cell research provides vast prospective to create new treatments for several serious diseases such as diabetes and heart disease. The location of the Helsinki Airport is the neighbouring city of Vantaa, which has frequent service to

many destinations in Europe and Asia. Helsinki was the World Design Capital for 2012.

 LIST OF UNIVERSITIES AROUND THE GLOBE:

University of Oxford

University of Washington

Stanford University

University of Tokyo

University of Cambridge

Icahn School of Medicine at Mount Sinai

University of Queensland Australia

McGill University

University of British Columbia

Aix-Marseille Universities

Karolinska Institute

University of Helsinki

London School of Hygiene & Tropical Medicine

University of Chicago

Top universities in Finland:

University of Helsinki

University of Tampere

Abo Akademi University

University of Oulu

University of Eastern Finland

University of Jyväskylä

Tampere University of Technology

University of Turku

Aalto University

Lappeenranta University of Technology